ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2015

Abstract Number: 909

Smoking Behavior Changes after Rheumatoid Arthritis Diagnosis and Risk of Mortality during 36 Years of Prospective Follow-up

Jeffrey A. Sparks1, Uyen Sa D.T. Nguyen2,3, Shun-Chiao Chang4,5, Yuqing Zhang6, Hyon Choi7 and Elizabeth W. Karlson4, 1Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Clinical Epidemiology Research &Training Unit, Boston University School of Medicine, Boston, MA, 3Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 4Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 5Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 6Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 7Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2015

Date of first publication: September 29, 2015

Keywords: morbidity and mortality, Public Health Approach, rheumatoid arthritis (RA) and risk

Session Information

Date: Sunday, November 8, 2015

Title: Epidemiology and Public Health I: RA Comorbidities and Mortality

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Smoking is a major preventable cause of death and cessation is recommended for the general population. However, it is unclear whether being diagnosis with RA affects smoking cessation and whether continuing to smoke contributes to the excess mortality of RA. We aimed to describe smoking behavior changes after RA diagnosis and to evaluate the effect of smoking on mortality after RA diagnosis.

Methods: We investigated smoking and mortality among women diagnosed with RA during follow-up in the Nurses’ Health Study (NHS). The NHS is composed of 121,700 women aged 30-55 years at baseline in 1976 and followed with biennial questionnaires. RA diagnosis was validated by medical record review according to the 1987 ACR criteria by two rheumatologists who identified the date of RA diagnosis. Smoking status and intensity (never, current, or past; cigarettes/day) were reported biennially during follow-up and cumulative smoking pack-years were calculated for each follow-up cycle. We categorized smoking at each follow-up cycle as occurring before or after the date of RA diagnosis. Deaths were identified by the National Death Index up to 2012. Cox regression models estimated HRs for all-cause mortality according to smoking pack-years after RA diagnosis, adjusting for sociodemographic, behavioral, and clinical factors.

Results: We analyzed 923 women diagnosed with RA during follow-up in the NHS with detailed prospective data available on smoking before and after RA diagnosis. There were 288 deaths in 16,111 person-years of follow-up. At RA diagnosis, mean age was 59.5 (SD 9.9) years, 52% were obese, and 60% consumed alcohol. In the cycle prior to RA diagnosis, 36% were never smokers, 43% were past smokers, and 21% were current smokers. Among current smokers just prior to RA diagnosis, 16% immediately quit smoking after RA diagnosis and maintained cessation, 21% continued to smoke throughout follow-up, 49% continued smoking for at least two cycles after RA but quit later, and 1% quit smoking after RA diagnosis then started smoking again later. Compared to never smokers after RA diagnosis, women who smoked >5 pack-years after RA diagnosis had significantly increased mortality (HR 2.69, 95% CI 1.33-5.46, Table) after adjustment for age, smoking pack-years prior to RA diagnosis, and other confounders. When analyzing only ever smokers at RA diagnosis, smoking >5 pack-years remained significantly associated with mortality compared to those who never smoked after RA diagnosis (HR 4.35, 95% CI 1.81-10.44).

Conclusion: Despite the known harmful effects of smoking in chronic diseases, only 16% of smokers quit after diagnosis with RA and maintained smoking cessation during follow-up. Smoking >5 pack-years after RA diagnosis was associated with increased mortality, independent of smoking before RA diagnosis. Interventions promoting cessation of smoking for patients newly diagnosed with RA may diminish the excess mortality of RA.

Table. Hazard ratios for all-cause mortality by cumulative smoking after RA diagnosis during 36 years of prospective follow-up in the Nurses’ Health Study, 1976-2012.

Cumulative smoking after RA diagnosis, N=923

Deaths/Person-years

Incidence (per 100,000)

Age and pre-RA smoking adjusted HR (95% CI)*

Multivariable HR (95% CI)**

Never/past/current smoker before RA and never smoker after RA diagnosis

184/12,307

1,529

1.00 (Ref)

1.00 (Ref)

>0-5 pack-years after RA diagnosis

44/2,070

2,126

1.49 (0.85-2.60)

1.42 (0.71-2.82)

>5 pack-years after RA diagnosis

60/1,734

3,460

2.98 (1.70-5.22)

2.69 (1.33-5.46)

 

Subgroup analysis: Cumulative smoking after RA diagnosis among ever smokers, N=590

Deaths/Person-years

Incidence (per 100,000)

Age and pre-RA smoking adjusted HR (95% CI)*

Multivariable HR (95% CI)**

Past/current smoker before RA and never smoker after RA diagnosis

113/6,172

1,831

1.00 (Ref)

1.00 (Ref)

>0-5 pack-years after RA diagnosis

44/2,070

2,126

1.50 (0.80-2.81)

1.68 (0.74-3.82)

>5 pack-years after RA diagnosis

60/1,734

3,460

3.88 (2.01-7.45)

4.35 (1.81-10.44)

*Adjusted for age, questionnaire period, and cumulative smoking prior to RA diagnosis (never, >0-10, >10-20, >20 pack-years)

**Additionally adjusted for median family income (<$40K, ≥$40K), body mass index category (underweight/normal, overweight, or obese), postmenopausal hormone (PMH) use (premenopausal or postmenopausal/never PMH use, postmenopausal/ever PMH use), physical activity (continuous METs-hours/week), alcohol consumption (0, >0-<5, ≥5 g/d), Alternate Healthy Eating Index without alcohol component (tertiles), cardiovascular disease, and aspirin use.


Disclosure: J. A. Sparks, None; U. S. D. T. Nguyen, None; S. C. Chang, None; Y. Zhang, None; H. Choi, None; E. W. Karlson, None.

To cite this abstract in AMA style:

Sparks JA, Nguyen USDT, Chang SC, Zhang Y, Choi H, Karlson EW. Smoking Behavior Changes after Rheumatoid Arthritis Diagnosis and Risk of Mortality during 36 Years of Prospective Follow-up [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/smoking-behavior-changes-after-rheumatoid-arthritis-diagnosis-and-risk-of-mortality-during-36-years-of-prospective-follow-up/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/smoking-behavior-changes-after-rheumatoid-arthritis-diagnosis-and-risk-of-mortality-during-36-years-of-prospective-follow-up/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology